Total Valuation
Ildong Pharmaceutical Co., Ltd. has a market cap or net worth of ₩398.10B. The enterprise value is $961.84K.
Market Cap₩398.10B
Enterprise Value$961.84K
Share Statistics
Ildong Pharmaceutical Co., Ltd. has 31,638,252 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,638,252
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ildong Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 2.79%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)2.79%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee548.82M
Profits Per Employee26.78M
Employee Count1,033
Asset Turnover0.99
Inventory Turnover3.50
Valuation Ratios
The current PE Ratio of Ildong Pharmaceutical Co., Ltd. is 12.2. Ildong Pharmaceutical Co., Ltd.’s PEG ratio is -0.06.
PE Ratio12.2
PS Ratio2.04
PB Ratio4.69
Price to Fair Value4.69
Price to FCF218.01
Price to Operating Cash Flow22.36
PEG Ratio-0.06
Income Statement
In the last 12 months, Ildong Pharmaceutical Co., Ltd. had revenue of 566.93B and earned 27.66B in profits. Earnings per share was 942.08.
Revenue566.93B
Gross Profit214.76B
Operating Income17.32B
Pretax Income31.80B
Net Income27.66B
EBITDA39.90B
Earnings Per Share (EPS)942.08
Cash Flow
In the last 12 months, operating cash flow was 17.33B and capital expenditures -15.82B, giving a free cash flow of 1.51B billion.
Operating Cash Flow17.33B
Free Cash Flow1.51B
Free Cash Flow per Share47.77
Dividends & Yields
Ildong Pharmaceutical Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.40
52-Week Price Change-25.89%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Ildong Pharmaceutical Co., Ltd. upcoming earnings date is Nov 17, 2026, TBA (Confirmed).
Last Earnings DateJul 30, 2026
Next Earnings DateNov 17, 2026
Ex-Dividend Date―
Financial Position
Ildong Pharmaceutical Co., Ltd. as a current ratio of 0.96, with Debt / Equity ratio of 53.94%
Current Ratio0.96
Quick Ratio0.53
Debt to Market Cap0.10
Net Debt to EBITDA2.14
Interest Coverage Ratio1.42
Taxes
In the past 12 months, Ildong Pharmaceutical Co., Ltd. has paid 8.08B in taxes.
Income Tax8.08B
Effective Tax Rate0.25
Enterprise Valuation
Ildong Pharmaceutical Co., Ltd. EV to EBITDA ratio is 31.12, with an EV/FCF ratio of 234.12.
EV to Sales2.19
EV to EBITDA31.12
EV to Free Cash Flow234.12
EV to Operating Cash Flow65.53
Balance Sheet
Ildong Pharmaceutical Co., Ltd. has ₩59.07B in cash and marketable securities with ₩133.65B in debt, giving a net cash position of -₩74.58B billion.
Cash & Marketable Securities₩59.07B
Total Debt₩133.65B
Net Cash-₩74.58B
Net Cash Per Share-₩2.36K
Tangible Book Value Per Share₩7.02K
Margins
Gross margin is 38.70%, with operating margin of 3.06%, and net profit margin of 4.88%.
Gross Margin38.70%
Operating Margin3.06%
Pretax Margin5.61%
Net Profit Margin4.88%
EBITDA Margin7.04%
EBIT Margin3.06%
Analyst Forecast
The average price target for Ildong Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.14%
EPS Growth Forecast―